These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

624 related items for PubMed ID: 15696400

  • 21. Acacetin, a natural flavone, selectively inhibits human atrial repolarization potassium currents and prevents atrial fibrillation in dogs.
    Li GR, Wang HB, Qin GW, Jin MW, Tang Q, Sun HY, Du XL, Deng XL, Zhang XH, Chen JB, Chen L, Xu XH, Cheng LC, Chiu SW, Tse HF, Vanhoutte PM, Lau CP.
    Circulation; 2008 May 13; 117(19):2449-57. PubMed ID: 18458165
    [Abstract] [Full Text] [Related]

  • 22. [A comparison between flecainide and sotalol in the prevention of recurrences of paroxysmal atrial fibrillation].
    Carunchio A, Fera MS, Mazza A, Burattini M, Greco G, Galati A, Ceci V.
    G Ital Cardiol; 1995 Jan 13; 25(1):51-68. PubMed ID: 7642012
    [Abstract] [Full Text] [Related]

  • 23. Effect of nifekalant on acute electrical remodelling in rapid atrial pacing canine model.
    Tang M, Zhang S, Sun Q, Hua W, Huang CX.
    Chin Med J (Engl); 2006 Dec 20; 119(24):2056-61. PubMed ID: 17199956
    [Abstract] [Full Text] [Related]

  • 24. Short QT syndrome: pharmacological treatment.
    Gaita F, Giustetto C, Bianchi F, Schimpf R, Haissaguerre M, Calò L, Brugada R, Antzelevitch C, Borggrefe M, Wolpert C.
    J Am Coll Cardiol; 2004 Apr 21; 43(8):1494-9. PubMed ID: 15093889
    [Abstract] [Full Text] [Related]

  • 25. Alterations in atrial electrophysiology associated with chronic atrial fibrillation in man.
    Kamalvand K, Tan K, Lloyd G, Gill J, Bucknall C, Sulke N.
    Eur Heart J; 1999 Jun 21; 20(12):888-95. PubMed ID: 10329094
    [Abstract] [Full Text] [Related]

  • 26. [Flecainide controlled-release for prevention of atrial fibrillation relapse].
    Simon T, Mary-Krause M, Chatelin A, Thuault M, Jaillon P, EPIFLEC.
    Arch Mal Coeur Vaiss; 2006 Feb 21; 99(2):109-16. PubMed ID: 16555693
    [Abstract] [Full Text] [Related]

  • 27. Treatment of resistant atrial fibrillation. A meta-analysis comparing amiodarone and flecainide.
    Zarembski DG, Nolan PE, Slack MK, Caruso AC.
    Arch Intern Med; 1995 Sep 25; 155(17):1885-91. PubMed ID: 7677555
    [Abstract] [Full Text] [Related]

  • 28. Atrial pacing for suppression of early reinitiation of atrial fibrillation after successful internal cardioversion.
    Tse HF, Lau CP, Ayers GM.
    Eur Heart J; 2000 Jul 25; 21(14):1167-76. PubMed ID: 10924300
    [Abstract] [Full Text] [Related]

  • 29. Ranolazine-induced postrepolarization refractoriness suppresses induction of atrial flutter and fibrillation in anesthetized rabbits.
    Aidonidis I, Doulas K, Hatziefthimiou A, Tagarakis G, Simopoulos V, Rizos I, Tsilimingas N, Molyvdas PA.
    J Cardiovasc Pharmacol Ther; 2013 Jan 25; 18(1):94-101. PubMed ID: 22872232
    [Abstract] [Full Text] [Related]

  • 30. Maintenance of sinus rhythm after electrical cardioversion of persistent atrial fibrillation; sotalol vs bisoprolol.
    Plewan A, Lehmann G, Ndrepepa G, Schreieck J, Alt EU, Schömig A, Schmitt C.
    Eur Heart J; 2001 Aug 25; 22(16):1504-10. PubMed ID: 11482924
    [Abstract] [Full Text] [Related]

  • 31. Block of IKs by the diuretic agent indapamide modulates cardiac electrophysiological effects of the class III antiarrhythmic drug dl-sotalol.
    Fiset C, Drolet B, Hamelin BA, Turgeon J.
    J Pharmacol Exp Ther; 1997 Oct 25; 283(1):148-56. PubMed ID: 9336319
    [Abstract] [Full Text] [Related]

  • 32. Temporal changes in atrial refractoriness following DC cardioversion of persistent atrial fibrillation in man.
    Spurrell P, Kamalvand K, Higson M, Sulke N.
    Europace; 2004 May 25; 6(3):229-35. PubMed ID: 15121076
    [Abstract] [Full Text] [Related]

  • 33. Effects of successful cardioversion of persistent atrial fibrillation on right ventricular refractoriness and repolarization.
    Manios EG, Kallergis EM, Kanoupakis EM, Mavrakis HE, Mouloudi HK, Klapsinos NK, Vardas PE.
    Europace; 2005 Jan 25; 7(1):34-9. PubMed ID: 15670965
    [Abstract] [Full Text] [Related]

  • 34. Atrial fibrillation begets atrial fibrillation in the pulmonary veins on the impact of atrial fibrillation on the electrophysiological properties of the pulmonary veins in humans.
    Rostock T, Steven D, Lutomsky B, Servatius H, Drewitz I, Klemm H, Müllerleile K, Ventura R, Meinertz T, Willems S.
    J Am Coll Cardiol; 2008 Jun 03; 51(22):2153-60. PubMed ID: 18510963
    [Abstract] [Full Text] [Related]

  • 35. Pharmacologic cardioversion of chronic atrial fibrillation in the goat by class IA, IC, and III drugs: a comparison between hydroquinidine, cibenzoline, flecainide, and d-sotalol.
    Wijffels MC, Dorland R, Allessie MA.
    J Cardiovasc Electrophysiol; 1999 Feb 03; 10(2):178-93. PubMed ID: 10090222
    [Abstract] [Full Text] [Related]

  • 36. Mixed treatment comparison of dronedarone, amiodarone, sotalol, flecainide, and propafenone, for the management of atrial fibrillation.
    Freemantle N, Lafuente-Lafuente C, Mitchell S, Eckert L, Reynolds M.
    Europace; 2011 Mar 03; 13(3):329-45. PubMed ID: 21227948
    [Abstract] [Full Text] [Related]

  • 37. [Intravenous flecainide administration for conversion of paroxysmal atrial fibrillation in the emergency room].
    Antonelli D, Feldman A, Freedberg NA, Darawsha A, Rosenfeld T.
    Harefuah; 2006 May 03; 145(5):342-4, 398. PubMed ID: 16805213
    [Abstract] [Full Text] [Related]

  • 38. Fractionation of electrograms and linking of activation during pharmacologic cardioversion of persistent atrial fibrillation in the goat.
    Shan Z, Van Der Voort PH, Blaauw Y, Duytschaever M, Allessie MA.
    J Cardiovasc Electrophysiol; 2004 May 03; 15(5):572-80. PubMed ID: 15149428
    [Abstract] [Full Text] [Related]

  • 39. Prospective comparison of flecainide versus sotalol for immediate cardioversion of atrial fibrillation.
    Reisinger J, Gatterer E, Heinze G, Wiesinger K, Zeindlhofer E, Gattermeier M, Poelzl G, Kratzer H, Ebner A, Hohenwallner W, Lenz K, Slany J, Kuhn P.
    Am J Cardiol; 1998 Jun 15; 81(12):1450-4. PubMed ID: 9645896
    [Abstract] [Full Text] [Related]

  • 40. Widening of the excitable gap during pharmacological cardioversion of atrial fibrillation in the goat: effects of cibenzoline, hydroquinidine, flecainide, and d-sotalol.
    Wijffels MC, Dorland R, Mast F, Allessie MA.
    Circulation; 2000 Jul 11; 102(2):260-7. PubMed ID: 10889140
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 32.